Cancer drug outperforms remdesivir against COVID-19 virus: Study
Researchers said pralatrexate, a drug originally developed to treat lymphoma, has outperformed remdesivir drug against SARS-CoV-2 in lab settings. Haiping Zhang of the Shenzhen Institutes of Advanced Technology and others screened 1,906 existing drugs for their potential ability to inhibit replication of SARS-CoV-2. Pralatrexate and azithromycin successfully inhibited replication of the virus.